Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 10/27/25 → 10/27/27 |
Financiación
- Crinetics Pharmaceuticals: 2,00 US$
25-NET-04-CPI-PMC (CRN09682-191): A Phase 1 Dose Escalation Study of CRN09682 With an Expansion Phase in Participants with Progressive Metastatic Somatostatin Receptor Type 2 (SST2)-Expressing Neuroendocrine Neoplasms (NENs) and Other SST2-Expressing Soli
- Anthony, Lowell (PI)